Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Critical Care Medicine|June 1, 1990
Pharmacokinetics of amikacin during continuous veno-venous hemofiltrationE Armendariz, L Chelluri, R PtachcinskiAmerican Journal of Hematology|July 1, 1992
Bleeding tendency, platelet function, and pharmacokinetics of ibuprofen and zidovudine in HIV(+) hemophilic menM V Ragni, B J Miller, R Whalen, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 21, 2021
Plerixafor strategies for autologous hematopoietic cell transplant mobilization: A comparison of efficacy and costKevin Y Chen, Tyler G Bucci, J Ryan Shaw, et al.Journal of Pharmacy Practice|July 28, 2018
Drug-Drug Interaction Between Isavuconazole and Tacrolimus: Is Empiric Dose Adjustment Necessary?Wesley D Kufel, Paul M Armistead, Lindsay M Daniels, et al.Transplantation|October 15, 1994
A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipientsM Martin, R Mañez, P Linden, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 18, 2020
Evaluation of mobilization efficacy with an extended interval following plerixafor administrationSarah E Stump, Morgan Trepte, J Ryan Shaw, et al.Journal of Clinical Pharmacology|May 1, 2023
Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test-Dose Strategy in Allogeneic Hematopoietic Cell Transplant RecipientsTyler C Dunlap, Daniel L Weiner, Ryan M Kemper, et al.Clinical and Translational Science|January 27, 2021
Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patientsJing Zhu, Olivia Campagne, Chad D Torrice, et al.Transplantation and Cellular Therapy|June 18, 2026
Evaluating day +90 donor chimerism as a prognostic marker of clinical outcomes among allogeneic hematopoietic cell transplant recipients who received myeloablative conditioningSara Jubas, Kieran Collins, Kendall Obara, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell TransplantationJessica M Davis, Anastasia Ivanova, Yunro Chung, et al.Pageof 2